OTLK
Outlook Therapeutics Inc
Price:  
1.48 
USD
Volume:  
786,563.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OTLK WACC - Weighted Average Cost of Capital

The WACC of Outlook Therapeutics Inc (OTLK) is 8.0%.

The Cost of Equity of Outlook Therapeutics Inc (OTLK) is 11.25%.
The Cost of Debt of Outlook Therapeutics Inc (OTLK) is 5.00%.

Range Selected
Cost of equity 7.40% - 15.10% 11.25%
Tax rate -% - 3.40% 1.70%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 9.9% 8.0%
WACC

OTLK WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 1.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 15.10%
Tax rate -% 3.40%
Debt/Equity ratio 1.02 1.02
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 9.9%
Selected WACC 8.0%